Clinical Research Directory
Browse clinical research sites, groups, and studies.
Spartina® (Tirzepatide) Effectiveness and Safety Evaluation
Sponsor: Cinnagen
Summary
The goal of this study is to evaluate Effectiveness and safety of Spartina® (Tirzepatide) in male or female participants with obesity and overweight. The main questions which are aimed to be answered: 1. Is Spartina® (Tirzepatide) effective in the treatment of obesity and overweight? 2. Is Spartina® (Tirzepatide) safe in the treatment of obesity and overweight? In this study, there is no comparison group. Participants receive Spartina® (Tirzepatide)
Official title: A Post-marketing Real-world Study for Evaluating Effectiveness and Safety of Spartina® (Tirzepatide Manufactured by CinnaGen) in Patients With Obesity and Overweight
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
175
Start Date
2025-11-11
Completion Date
2026-04
Last Updated
2025-12-16
Healthy Volunteers
No
Conditions
Locations (14)
Akbar Aliasgarzadeh Clinic
Tabriz, East Azerbaijan Province, Iran
Dr. Mohammadhossein Dabbaghmanesh Clinic
Shiraz, Fars, Iran
Behrang Motamed Clinic
Rasht, Gilan Province, Iran
Seyed Mojtaba Mehrdad Clinic
Rasht, Gilan Province, Iran
Mansoor Siavash Dastjerdi Clinic
Isfahan, Isfahan, Iran
Shokoofeh Bonakdaran Clininc
Mashhad, Khorasan Razavi, Iran
Sari Diabetes Research Center
Sari, Mazandaran, Iran
Alireza Esteghamati clinic
Tehran, Tehran Province, Iran
Farzad Hadaegh Clininc
Tehran, Tehran Province, Iran
Imam Khomeini Hospital
Tehran, Tehran Province, Iran
Iran University Endocrinology Research Center
Tehran, Tehran Province, Iran
Mohammadreza Mohajeri Tehrani Clininc
Tehran, Tehran Province, Iran
Khorshid Clinic
Yazd, Yazd Province, Iran
Hajieh Bibi Shahbazian Clinic
Ahvāz, Iran